P2RY12 and cancer: Indeed, the use of antiplatelet drugs—such as aspirin, P2Y12 inhibitors, and GPIIb/IIIa antagonists—has been studied extensively in contexts such as viral infections, sepsis, diabetes, cancer, and cardiovascular diseases, and further research is needed to explore their impact on other immunological conditions, including allergies, autoimmune disorders, and chronic inflammatory diseases.